Document is current
Any future updates will be listed below
-
Authors
Andrade, Viviane M. https://orcid.org/0000-0002-5056-298X
Cashman, Kathleen
Rosenke, Kyle
Wilkinson, Eric
Josleyn, Nicole
Lynn, Ginger
Steffens, Jesse
Vantongeren, Sean
Wells, Jay
Schmaljohn, Connie
Facemire, Paul
Jiang, Jingjing
Boyer, Jean
Patel, Aditya
Feldmann, Friederike https://orcid.org/0000-0002-1363-1077
Hanley, Patrick https://orcid.org/0000-0003-2300-1818
Lovaglio, Jamie https://orcid.org/0000-0002-7567-446X
White, Kimberly
Feldmann, Heinz https://orcid.org/0000-0001-9448-8227
Ramos, Stephanie
Broderick, Kate E.
Humeau, Laurent M.
Smith, Trevor R. F. https://orcid.org/0000-0002-0671-2565
-
Funding
Funding for this research was provided by:
Coalition for Epidemic Preparedness Innovations
- License Information
-
More Information
Article History
Received: 16 January 2024
Accepted: 19 November 2024
First Online: 28 November 2024
Competing interests
: V.M.A., T.R.F.S., and L.M.H. are employees of Inovio Pharmaceuticals and as such receive salary and benefits, including ownership of stock and stock options from the company. J.J., J.B., A.P., S.R., and K.E.B. are former Inovio employees. All other authors declare no competing interest.
